EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity

Andrew M Brandon, Steven R Baginski iD, Caroline Peet, Pat Dugard, Henrik Green iD, Oliver B Sutcliffe iD, Niamh Nic Daéid iD, Lorna A Nisbet iD, Kevin D Read, Craig McKenzie

Drug Testing and Analysis · 2024-09 · 16 (9) · 1012-1025

DOI: 10.1002/dta.3621 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, online erschienen am 08.12.2023. Verfasst von Andrew M Brandon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Hydrophobic and Hydrophilic Interactions, Protein Binding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Leverhulme Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of new synthetic cannabinoid receptor agonists (SCRAs) onto the illicit drugs market continues to cause harm, and the overall availability of physicochemical and pharmacokinetic data for new psychoactive substances is lacking. The lipophilicity of 23 SCRAs and the plasma protein binding (PPB) of 11 SCRAs was determined. Lipophilicity was determined using a validated chromatographic hydrophobicity index (CHI) log D method; tested SCRAs showed moderate to high lipophilicity, with experimental log D 7.4 ranging from 2.48 (AB‐FUBINACA) to 4.95 (4F‐ABUTINACA). These results were also compared to in silico predictions generated using seven commercially available software packages and online tools (Canvas; ChemDraw; Gastroplus; MoKa; PreADMET; SwissADME; and XlogP). Licenced, dedicated software packages provided more accurate lipophilicity predictions than those which were free or had prediction as a secondary function; however, the latter still provided competitive estimates in most cases. PPB of tested SCRAs, as determined by equilibrium dialysis, was in the upper range of the lipophilicity scale, ranging from 90.8% (ADB‐BUTINACA) to 99.9% (BZO‐HEXOXIZID). The high PPB of these drugs may contribute to reduced rate of clearance and extended durations of pharmacological effects compared to lesser‐bound SCRAs. The presented data improve understanding of the behaviour of these drugs in the body. Ultimately, similar data and predictions may be used in the prediction of the structure and properties of drugs yet to emerge on the illicit market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cannabinoid Receptor AgonistsHydrophobic and Hydrophilic InteractionsProtein BindingHumansIllicit DrugsBlood ProteinsSoftwareComputer SimulationCannabinoids

Stichwörter der Autor:innen

lipophilicitynew psychoactive substancespharmacokineticsplasma protein bindingsynthetic cannabinoid receptor agonists

Substanzen

Cannabinoid Receptor AgonistsIllicit DrugsBlood ProteinsCannabinoids

Autor:innen und Institutionen

  • Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK.
  • Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK.
  • Debiopharm, Lausanne, Switzerland.
  • Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
  • Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

ORCID-Profile: Steven R Baginski, Henrik Green, Oliver B Sutcliffe, Niamh Nic Daéid, Lorna A Nisbet

Förderung

  • Engineering and Physical Sciences Research Council
  • Leverhulme Trust

Zitieren

APA

Brandon, A. M., Baginski, S. R., Peet, C., Dugard, P., Green, H., Sutcliffe, O. B., Daéid, N. N., Nisbet, L. A., Read, K. D., & McKenzie, C. (2024). Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity. Drug Testing and Analysis, 16(9), 1012-1025. https://doi.org/10.1002/dta.3621

Vancouver

Brandon AM, Baginski SR, Peet C, Dugard P, Green H, Sutcliffe OB, et al. Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity. Drug Testing and Analysis. 2024;16(9):1012-1025. doi:10.1002/dta.3621

BibTeX
@article{Brandon2024,
  author = {Brandon, Andrew M and Baginski, Steven R and Peet, Caroline and Dugard, Pat and Green, Henrik and Sutcliffe, Oliver B and Daéid, Niamh Nic and Nisbet, Lorna A and Read, Kevin D and McKenzie, Craig},
  title = {Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity},
  journal = {Drug Testing and Analysis},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1012--1025},
  doi = {10.1002/dta.3621}
}
Kostenlos starten →